Tuesday, January 30, 2007 7:00:00 AM PDT | VentureDeal Staff
DURHAM, NC -- InnerPulse
Inc. announced the closing of a $50 million series C round of new
The company develops technologies that treat abnormal heart rhythms and its
first product, an implantable heart defibrillator, is moving through
development. The new investment will be used to complete development on
the product and ready it for clinical human trials and ultimately
Investors included Johnson & Johnson Development Corp, Medtronic, Synergy
Life Science Partners, Ascent BioMedical Ventures, Delphi Ventures and Frazier
Email Page | Print Page
Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?
Start your Free 14 Day Trial now – no obligation or credit card required.
Founded in 2006, VentureDeal is a database that provides the latest information about venture capital firms, venture-backed technology companies and transactions throughout North America.
Learn More »
© VentureDeal, Inc., Menlo Park, CA. All Rights Reserved.